Liquid Biopsy in Pediatric Renal Cancer: Stage I and Stage IV Cases Compared

Pediatric renal cancer is rare, and robust evidence for treatment recommendations is lacking. In the perspective of personalized medicine, clinicians need new biomarkers to improve risk stratification and patients’ follow-up. Herein, we analyzed some liquid biopsy tools, which have been never tested...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Elisabetta, Zin, Angelica, Facchinetti, Antonella, Poggiana, Cristina, Tombolan, Lucia, Affinita, Maria Carmen, Bonvini, Paolo, Santoro, Luisa, Schiavi, Francesca, Bisogno, Gianni, Zamarchi, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599903/
https://www.ncbi.nlm.nih.gov/pubmed/33053902
http://dx.doi.org/10.3390/diagnostics10100810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599903/
https://www.ncbi.nlm.nih.gov/pubmed/33053902
http://dx.doi.org/10.3390/diagnostics10100810

Ejemplares similares